http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-I661046-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3771221a4acf1922ce66c3eb60e291de |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0786 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00 |
| filingDate | 2017-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b5a08a3e046b2eab2a3fddfac10619ee |
| publicationDate | 2019-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | TW-I661046-B |
| titleOfInvention | M2C macrophage cell strain and application thereof |
| abstract | The present invention provides an M2C macrophage cell strain and an application thereof, which are separated from bone marrow or peripheral blood by a single cell, and differentiated by a macrophage colony-stimulating factor M-CSF (Macrophage colony-stimulating factor). For M2 macrophages, M2C macrophages induced by baicalin were differentiated. The M2C macrophage cell lines MERTK, PTX3, and PD-L1 have high expression levels and promote cell phagocytosis, and can be used for cell therapy or biological preparations for regulating immunity. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-I758020-B |
| priorityDate | 2017-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 285.